Position
Chief Financial Officer
Company
Protalix BioTherapeutics
KarmielManufacturingBiotechnologyTherapeuticsBiopharmaDescription
Protalix BioTherapeutics has appointed Gilad Mamlok as the new Chief Financial Officer, effective August 24, 2025. He succeeds Eyal Rubin, who will assist during the transition period until October 2025.
Quick answer
Protalix BioTherapeutics Appoints Gilad Mamlok as Chief Financial Officer (July 21, 2025). Protalix BioTherapeutics is based in Karmiel, North District, Israel.
- Who is the new Chief Financial Officer at Protalix BioTherapeutics?
- Protalix BioTherapeutics named Gilad Mamlok Chief Financial Officer, announced July 21, 2025.
- What did Protalix BioTherapeutics announce on July 21, 2025?
- Protalix BioTherapeutics has appointed Gilad Mamlok as the new Chief Financial Officer, effective August 24, 2025. He succeeds Eyal Rubin, who will assist during the transition period until October 2025.
- What does Protalix BioTherapeutics do?
- Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx.
- Where is Protalix BioTherapeutics based?
- Protalix BioTherapeutics is based in Karmiel, North District, Israel.
- Which similar companies made leadership changes around the same time?
- CASI Pharmaceuticals (July 21, 2025), Jazz Pharmaceuticals plc (July 10, 2025), PolyPid (August 12, 2025) and MacroGenics (August 13, 2025) also announced leadership changes within 45 days of Protalix BioTherapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- CASI Pharmaceuticals Appoints David Cory as Chief Executive Officer (July 21, 2025)
- Jazz Pharmaceuticals Appoints Renee Gala as Chief Executive Officer (July 10, 2025)
- PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer (August 12, 2025)
- MacroGenics Appoints Eric Risser as President and Chief Executive Officer (August 13, 2025)
- Hansa Biopharma Appoints Brian Gorman as Chief Legal Officer and Sandra Frithiof as Chief Human Resources Officer (July 29, 2025)
- ImageneBio Appoints Kristin Yarema as Chief Executive Officer (August 1, 2025)
Who to call at Protalix BioTherapeutics, and when
A new leader at Protalix BioTherapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Protalix BioTherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Protalix BioTherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Protalix BioTherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Protalix BioTherapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Protalix BioTherapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.